Rubia, Cerilo A.

HRN: 05-32-30  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/24/2025
CEFTRIAXONE 1G (VIAL)
07/24/2025
07/31/2025
IV
2g
Q 24H
Ruptured Viscus
Remove - Pending Acceptance
07/24/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/24/2025
08/20/2025
IV
500mg
Q8H
Ruptured Viscus
Remove - Pending Acceptance
07/24/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/24/2025
08/10/2025
IV
2.25g
Q8H
Ruptured Viscus
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: